Vitamins C and E and LDL Oxidation

Vitamins and Hormones

Volumn 52, Issue C, 1996, Pages 1-34

  Frei, Balz ^a   Keaney Jr , John F ^a   Retsky, Karen L ^a   Chen, Kent ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; LOW DENSITY LIPOPROTEIN;

ARTERIOSCLEROSIS; HUMAN; LIPID PEROXIDATION; METABOLISM; REVIEW;

ANTIOXIDANTS; ARTERIOSCLEROSIS; ASCORBIC ACID; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; VITAMIN E;

EID: 0029683270     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)60405-7     Document Type: Chapter

References (122)

1. Abbey M., Nestel P.J., and Baghurst P.A. Antioxidant vitamins and low-density-lipoprotein oxidation. Am. J. Clin. Nutr. 58 (1993) 525-532
2. Abdalla D.S.P., Campa A., and Monteiro H.P. Low density lipoprotein oxidation by stimulated neutrophils and ferritin. Atherosclerosis 97 (1992) 149-159
3. Aviram M. Modified forms of low density lipoprotein affect platelet aggregation in vitro. Thromb. Res. 53 (1989) 561-567
4. Babiy A., Gebicki J.M., and Sullivan D.R. Vitamin E content and low density lipoprotein oxidizability induced by free radicals. Atherosclerosis 81 (1990) 175-182
5. Balla G., Jacob J.S., Eaton J.W., Belcher J.D., and Vercellotti G.M. Hemin: A possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler. Thromb. 11 (1991) 1700-1711
6. Bedwell S., Dean R.T., and Jessup W. The action of defined oxygen-centered free radicals on human low-density lipoprotein. Biochem. J. 262 (1989) 707-712
7. Belcher J.D., Balla J., Balla G., Jacobs Jr. D.R., Gross M., Jacob H.S., and Vercellotti G.M. Vitamin E, LDL and endothelium: Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arterioscler. Thromb. 13 (1993) 1779-1789
8. Bendich A., Machlin L.J., Scandurra O., Burton G.W., and Wayner D.D.M. The antioxidant role of vitamin C. Adv. Free Radical Biol. Med. 2 (1986) 419-444
9. Benedetti A., Comporti M., and Esterbauer H. Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim. Biophys. Acta 620 (1980) 281-296
10. Berliner J.A., Territo M.C., Sevanian A., Ramin S., Kim J.A., Bamshad B., Esterson M., and Fogelman A. Minimally modified LDL stimulates monocyte endothelial interactions. J. Clin. Invest. 85 (1990) 1260-1266
11. Berliner J.A., and Heinecke J. The role of oxidized lipoproteins in atherogenesis. Free Radical Biol. Med. 20 (1996) 707-727
12. Boulanger C.M., Tanner F.C., Bea M.L., Hahn A.W., Werner A., and Lüscher T.F. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ. Res. 70 (1992) 1191-1197
13. Bowry V.W., and Stocker R. Tocopherol-mediated peroxidation: The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J. Am. Chem. Soc. 115 (1993) 6029-6044
14. Bowry V., Ingold K.U., and Stocker R. Vitamin E in human low-density lipoprotein: When and how this antioxidant becomes a pro-oxidant. Biochem. J. 288 (1992) 341-344
15. Brown M.S., and Goldstein J.L. A receptor-mediated pathway for cholesterol homeostatis. Science 232 (1986) 34-47
16. Coffey M.D., Cole R.A., Colles S.M., and Chisolm G.M. In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals. J. Clin. Invest. 96 (1995) 1866-1873
17. Cominacini L., Garbin U., Cenci B., Davoli A., Pasini C., Ratti E., Gabiraghi G., Lo Cascio V., and Pastorino A.M. Predisposition to LDL oxidation during copper-catalyzed oxidative modification and its relation to α-tocopherol content in humans. Clin. Chim. Acta 204 (1991) 57-68
18. Crawford D.W., and Blankenhorn D.H. Arterial wall oxygenation, oxyradicals, and atherosclerosis. Atherosclerosis 89 (1991) 97-108
19. Dabbagh A.J., and Frei B. Human suction blister interstitial fluid prevents metal ion-dependent oxidation of low density lipoprotein by macrophages and in cell-free systems. J. Clin. Invest. 96 (1995) 1958-1966
20. Dieber-Rotheneder M., Puhl H., Waeg H., Striegl G., and Esterbauer H. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J. Lipid Res. 32 (1991) 1325-1332
21. Drake T.A., Hannani K., Fei H.H., Lavi S., and Berliner J.A. Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am. J. Pathol. 138 (1991) 601-607
22. Endemann G., Stanton L.W., Madden K.S., Bryant C.M., White R.T., and Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J. Biol Chem. 268 (1993) 11811-11816
23. Esterbauer H., Jürgens G., Quehenberger O., and Koller E. Autoxidation of human low density lipoprotein: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res. 28 (1987) 495-509
24. Esterbauer H., Striegl G., Puhl H., Oberreither S., Rotheneder M., El-Saadani M., and Jürgens J. The role of vitamin E and carotenoids in preventing oxidation of low density lipoprotein. Ann. N.Y. Acad. Sci. 570 (1989) 254-267
25. Esterbauer H., Dieber-Rotheneder M., Waeg F., Striegl G., and Jürgens G. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem. Res. Toxicol. 3 (1990) 77-92
26. Esterbauer H., Dieber-Rotheneder M., Striegl G., and Waeg G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am. J. Clin. Nutr. 53 Suppl (1991) 314S-321S
27. Esterbauer H., Gebicki J., Puhl H., and Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biol. Med. 13 (1992) 341-390
28. Flavahan N.A. Atherosclerosis of lipoprotein-induced endothelial dysfunction: Potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 85 (1992) 1927-1938
29. Freeman M., Ekkel Y., Rohrer L., Penman M., Freedman N.J., Chisolm G.M., and Krieger M. Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: Lipid droplet accumulation and nonreciprocal cross competition by acetylated oxidized low density lipoprotein. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 4931-4935
30. Frei B. Cardiovascular disease and nutrient antioxidants: Role of low-density lipoprotein oxidation. Crit. Rev. Food Sci. Nutr. 35 (1995) 83-98
31. Frei B., and Gaziano J.M. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J. Lipid Res. 34 (1993) 2135-2145
32. Frei B., and Lynch S.M. Effects of combined supplementation with antioxidants on low-density lipoprotein oxidation. Circulation 90 (1994) 3119
33. Frei B., Stocker R., and Ames B.N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 9748-9752
34. Frei B., England L., and Ames B.N. Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 6377-6381
35. Frei B., Stocker R., England L., and Ames B.N. Ascorbate: The most effective antioxidant in human blood plasma. Adv. Exp. Med. Biol. 264 (1990) 155-163
36. Frei B., Forte T., Ames B.N., and Cross C.E. Gas-phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma: Protective effects of ascorbic acid. Biochem. J. 277 (1991) 133-138
37. Frei B., Stocker R., and Ames B.N. Small molecule antioxidant defenses in human extracellular fluids. In: Scandalios J. (Ed). "The Molecular Biology of Free Radical Scavenging Systems" (1992), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 23-45
38. Frostegard J., Haegerstrand A., Giglund M., and Nilsson J. Biologically modified LDL increases the adhesive properties of endothelial cells. Atherosclerosis 90 (1991) 119-126
39. Gaziano M.J., Manson J.E., and Hennekens C.H. Natural antioxidants and cardiovascular disease: Observational epidemiologic studies and randomized trials. In: Frei B. (Ed). "Natural Antioxidants in Human Health and Disease" (1994), Academic Press, San Diego 387-410
40. Gieseg S.P., and Esterbauer H. Low density lipoprotein is saturable by prooxidant copper. FEBS Lett. 343 (1994) 188-194
41. Goldstein J.L., Ho Y.K., Basu S.K., and Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 333-337
42. Gotto A.J., and Farmer J.A. Risk factors for coronary artery disease. In: Braunwald E. (Ed). "Heart Disease: A Textbook of Cardiovascular Medicine," 3rd ed. (1988), W. B. Saunders, Philadelphia 1153-1190
43. Haberland M.E., Olch C.L., and Fogelman A.M. Role of lysines in mediating interaction of modified low density lipoproteins with the scavenger receptor of human monocyte macrophages. J. Biol. Chem. 259 (1984) 11305-11311
44. Hajjar D.P., Farber I.C., and Smith S.C. Oxygen tension within the arterial wall: Relationship to altered bioenergetic metabolism and lipid accumulation. Arch. Biochem. Biophys. 262 (1988) 375-380
45. Halliwell B., Wasil M., and Grootveld M. Biologically significant scavenging of the myeloperoxidase-derived oxidant hypochlorous acid by ascorbic acid: Implications for antioxidant protection in the inflamed rheumatoid joint. FEBS Lett. 213 (1987) 15-17
46. Harats D., Ben-Naim M., Dabach Y., Hollander G., Havivi E., Stein O., and Stein Y. Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis 85 (1990) 47-54
47. Hatta A., and Frei B. Oxidative modification and antioxidant protection of human low-density lipoprotein at high and low oxygen partial pressures. J. Lipid Res. 36 (1995) 2383-2393
48. Hazell L.J., and Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem. J. 290 (1993) 165-172
49. Hazell L.J., van den Berg J.J., and Stocker R. Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation. Biochem. J. 302 (1994) 297-304
50. Heinecke J.W., Baker L., Rosen H., and Chait A. Superoxide mediated modification of low density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest. 77 (1986) 757-761
51. Heinecke J.W., Rosen H., Suzuki L.A., and Chait A. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoproteins by arterial smooth muscle cells. J. Biol. Chem. 62 (1987) 10098-10103
52. Henriksen T., Mahoney E.M., and Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptor for acetylated low density lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 6499-6503
53. Hunter E.P.L., Desrosiers M.R., and Simic M.G. The effect of oxygen, antioxidants, and superoxide radical on tyrosine phenoxyl radical dimerization. Free Radical Biol. Med. 6 (1989) 581-585
54. Ingold K.U., Bowry V.W., Stocker R., and Walling C. Autoxidation of lipids and antioxidation by α-tocopherol and uniquinol in homogeneous solution and in aqueous dispersions of lipids: Unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 45-49
55. Iwatsuki M., Kiki E., Stone D., and Darley-Usmar V.M. α-Tocopherol mediated peroxidation in the copper (II) and met myoglobin induced oxidation of human low density lipoprotein: The influence of lipid hydroperoxides. FEBS Lett. 360 (1995) 271-276
56. Jessup W., Rankin S.M., De Whalley C.V., Hoult J.R.S., Scott J., and Leake D.S. Alpha-tocopherol consumption during low-density-lipoprotein oxidation. Biochem. J. 265 (1990) 399-405
57. Jialal I., and Grundy S.M. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J. Clin. Invest. 87 (1991) 597-601
58. Jialal I., and Grundy S.M. Effect of dietary supplementation with alphatocopherol on the oxidative modification of low density lipoprotein. J. Lipid Res. 33 (1992) 899-906
59. Jialal I., and Grundy S.M. Effect of combined supplementation with α-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation. Circulation 88 (1993) 2780-2786
60. Jialal I., Vega G.L., and Grundy S.M. Physiologic levels of ascorbate inhibit oxidative modification of low density lipoprotein. Atherosclerosis 82 (1990) 185-191
61. Jialal I., Fuller C.J., and Huet B.A. The effect of α-tocopherol supplementation on LDL oxidation: A dose-response study. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 190-198
62. Kagan V.E., Serbinova E.A., Forte T., Scita G., and Packer L. Recycling of vitamin E in human low density lipoproteins. J. Lipid Res. 33 (1992) 385-397
63. Keaney Jr. J.F., and Frei B. Antioxidant protection of low-density lipoprotein and its role in the prevention of atherosclerotic vascular disease. In: Frei B. (Ed). "Natural Antioxidants in Human Health and Disease" (1994), Academic Press, San Diego 303-351
64. Keaney Jr. J.F., Gaziano J.M., Xu A., Frei B., Curran-Celantano J., Shwaery G.T., Loscalzo J., and Vita J.A. Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 11880-11884
65. Khoo J.C., Miller E., Pio F., Steinberg D., and Witztum J.L. Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates. Arterioscler. Thromb. 12 (1992) 1258-1266
66. Kim J.A., Territo M.C., Wayner E., Carlos T.M., Parhami F., Smith C.W., Haberland M.E., Fogelman A.M., and Berliner J.A. Partial characterization of leukocyte binding molecules on endothelial cells induced minimally oxidized LDL. Arterioscler. Thromb. 14 (1994) 427-433
67. Krieger M., and Herz J. Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63 (1994) 601-637
68. Kritharides L., Jessup W., and Dean R.T. Macrophages require both iron and copper to oxidize low-density lipoprotein in Hanks' balanced salt solution. Arch. Biochem. Biophys. 323 (1995) 127-136
69. Kuzuya M., Yamada K., Hayashi T., Funaki C., Naito M., Asai K., and Kuzuya F. Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoprotein. Biochim. Biophys. Acta 1123 (1992) 334-341
70. Latron Y., Chautan M., Anfosso F., Alessi M.C., Nalbone G., Lafont H., and Juhan-Vague I. Stimulating effect of oxidized low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cells. Arterioscler. Thromb. 11 (1991) 1821-1829
71. Leake D.S., and Rankin S.M. The oxidative modification of low-density lipoproteins by macrophages. Biochem. J. 270 (1990) 741-748
72. Lynch S.M., and Frei B. Mechanisms of copper- and iron-dependent oxidative modification of human low-density lipoprotein. J. Lipid Res. 34 (1993) 1745-1753
73. Lynch S.M., and Frei B. Reduction of copper, but not iron, by human low density lipoprotein (LDL). Implications for metal ion-dependent oxidative modification of LDL. J. Biol. Chem. 270 (1995) 5158-5163
74. Lynch S.M., Morrow J.D., Roberts II L.J., and Frei B. Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J. Clin. Invest. 93 (1994) 998-1004
75. Lynch S.M., Gaziano J.M., and Frei B. Ascorbic acid and atherosclerotic cardiovascular disease. In: Harris J.R. (Ed). "Ascorbic Acid: Biochemistry and Biomedical Cell Biology" (1995), Plenum Press, New York 331-367
76. Ma Y.S., Stone W.L., and LeClair I.O. The effects of vitamin C and urate on the oxidation kinetics of human low-density lipoprotein. Proc. Soc. Exp. Biol. Med. 206 (1994) 53-59
77. Miller N.J., Paganga G., Wiseman S., Van Nielen W., Tijburg L., Chowienczyk P., and Rice-Evans C.A. Total antioxidant activity of low density lipoproteins and the relationship with α-tocopherol status. FEBS Lett. 365 (1995) 164-166
78. Minotti G., and Aust S.D. The role of iron in the initiation of lipid peroxidation. Chem. Phys. Lipids 44 (1987) 191-208
79. Moore K.P., Darley-Usmar V., Morrow J., and Roberts II L.J. Formation of F2-isoprostanes during oxidation of human low-densityh lipoprotein and plasma by peroxynitrite. Circ. Res. 77 (1995) 335-341
80. Morel D.W., DiCorleto P.E., and Chisolm G.M. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 4 (1984) 357-364
81. Naseem K.M., Goodall A.H., and Bruckdorfer K.R. The effects of native and oxidised low density lipoproteins on platelet activation. Biochem. Soc. Trans. 21 (1993) 140S
82. Recommended Dietary Allowances, 10th ed. (1989), National Academy Press, Washington, DC National Research Council.
83. Neuzil J., and Stocker R. Free and albumin-bound bilirubin are efficient coantioxidants for α-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J. Biol. Chem. 269 (1994) 16712-16719
84. Nishikimi M. Oxidation of ascorbic acid with superoxide anion generated by the xanthine-xanthine oxidase system. Biochem. Biophys. Res. Commun. 63 (1975) 463-468
85. Ottnad E., Parthasarathy S., Sambrano G.R., Ramprasad M.P., Quehenberger O., Kondratenko N., Green S., and Steinberg D. A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: Partial purification and role in recognition of oxidatively damaged cells. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 1391-1395
86. Palinski W., Rosenfeld M.E., Ylä-Herttuala S., Gurtner G.C., Socher S.S., Butler S.W., Parthasarathy S., Carew T.E., Steinberg D., and Witztum J.L. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Nat. Acad. Sci. U.S.A. 86 (1989) 1372-1376
87. Parhami F., Fang Z.T., Fogelman A.M., Andalibi A., Territo M.C., and Berliner J.A. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J. Clin. Invest. 92 (1993) 471-478
88. Parasarathy S., Printz D.J., Boyd D., Joy L., and Steinberg D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis 6 (1986) 505-510
89. Princen H.M., van Poppel G., Vogelezang C., Buytenhek R., and Kok F.J. Supplementation with vitamin E but not β-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro: Effect of cigarette smoking. Arterioscler. Thromb. 12 (1992) 554-562
90. Princen H.M.G., van Duyvenvoorde W., Buytenhek R., van der Laarse A., van Poppel G., Leuven J.A.G., and van Hinsbergh V.W.M. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 325-333
91. Quinn M.T., Parthasarathy S., Fong L.G., and Steinberg D. Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 2995-2998
92. Quinn M.T., Parthasarathy S., and Steinberg D. Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential rote in atherogenesis. Proc. Natl. Acad. Sci. U.S.A. 84 (1988) 1372-1376
93. Reaven P.D., and Witztum J.L. Comparison of supplementation of RRR-α-tocopherol and racemic α-tocopherol in humans: Effects of lipid levels and lipoprotein susceptibility to oxidation. Arterioscler, Thromb. 13 (1993) 601-608
94. Reaven P., Parthasarathy S., Grasse B.J., Miller E., Almazan F., Mattson F.H., Khoo J.C., Steinberg D., and Witztum J.L. Feasibility of using an oleaterich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans. Am. J. Clin. Nutr. 54 (1991) 701-706
95. Reaven P.D., Khouw A., Beltz W.F., Parthasarathy S., and Witztum J.L. Effect of dietary antioxidant combinations in humans: Protection of LDL by vitamin E but not beta-carotene. Arterioscler. Thromb. 13 (1993) 590-600
96. Retsky K.L., and Frei B. Vitamin C prevents metal ion-dependent initiation and propagation of lipid peroxidation in human low density lipoprotein. Biochim. Biophys. Acta. 1257 (1995) 279-287
97. Retsky K.L., Freeman M.W., and Frei B. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification: Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions. J. Biol. Chem. 268 (1993) 1304-1309
98. Rifici V.A., and Khachadurian A.K. Dietary supplementation with vitamins C and E inhibits in vitro oxidation of lipoproteins. J. Am. Coll. Nutr. 12 (1993) 631-637
99. Samuni A., Aronovitch J., Godinger D., Chevion M., and Czapski G. On the cytotoxicity of vitamin C and metal ions: A site-specific Fenton mechanism. Eur. J. Biochem. 137 (1983) 119-124
100. Sato K., Niki E., and Shimasaki H. Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and C. Arch. Biochem. Biophys. 279 (1990) 402-405
101. Savenkova M.I., Mueller D.M., and Heinecke J.W. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 269 (1994) 20394-20400
102. Schwartz C.J., and Valente A.J. The pathogenesis of atherosclerosis. In: Frei B. (Ed). "Natural Antioxidants in Human Health and Disease" (1994), Academic Press, San Diego 287-302
103. Shaish A., Daugherty A., O'Sullivan F., Schonfeld G., and Heinecke J.W. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J. Clin. Invest. 96 (1995) 2075-2082
104. Smith D., O'Leary V.J., and Darley-Usmar V.M. The role of α-tocopherol as a peroxyl radical scavenger in human low density lipoprotein. Biochem. Parmacol. 45 (1993) 2195-2201
105. Sparrow C.P., and Olszewski J. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J. Lipid Res. 34 (1993) 1219-1228
106. Sparrow C.P., Parthasarathy S., and Steinberg D. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J. Biol. Chem. 264 (1989) 2599-2604
107. Stait S.E., and Leake D.S. Ascorbic acid can either increase or decrease low density lipoprotein modification. FEBS Lett. 341 (1994) 263-267
108. Stanton L.W., White R.T., Bryant C.M., Protter A.A., and Endemann G. A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J. Biol. Chem. 267 (1992) 22446-22451
109. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., and Witztum J.L. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. New Engl. J. Med. 320 (1989) 915-924
110. Steinbrecher U.P. Oxidation of human low-density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. Chem. 262 (1987) 3603-3608
111. Steinbrecher U.P. Role of superoxide in endothelial-cell modification of low-density lipoproteins. Biochim. Biophys. Acta. 959 (1988) 20-30
112. Steinbrecher U.P., Parthasarathy S., Leake D.S., Witztum J.L., and Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 3883-3887
113. Stocker R., and Frei B. Endogenous antioxidant defences in human blood plasma. In: Sies H. (Ed). "Oxidative Stress: Oxidants and Antioxidants" (1991), Acaademic Press, London 213-243
114. Stocker R., Bowry V.W., and Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 1646-1650
115. Sugiyama S., Kugiyama K., Ohgushi M., Fujimoto K., and Yasue H. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries: Role of protein kinase C. Circ. Res. 74 (1994) 565-575
116. Suits A.G., Chait A., Aviram M., and Heinecke J.W. Phagocytosis of aggregated lipoprotein by macrophages: Low density lipoprotein receptor-dependent foam-cell formation. Proc. Nat. Acad. Sci. U.S.A. 86 (1989) 2713-2717
117. Thorin E., Hamilton C.A., Dominiczak M.H., and Reid J.L. Chronic exposure of cultured bovine endothelial cells to oxidized LDL abolishes prostacyclin release. Arterioscler. Thromb. 14 (1994) 453-459
118. Uchida K., and Kawakishi S. Site-specific oxidation of angiotensin I by copper(II) and L-ascorbate: Conversion of histidine residues to 2-imidazolones. Arch. Biochem. Biophys. 283 (1990) 20-26
119. van Hinsbergh V.W.M., Scheffer M., Havekes L., and Kempen H.J.M. Role of endothelial cells and their products in the modification of low-density lipoproteins. Biochim. Biophys. Acta 878 (1986) 49-64
120. Weis J.R., Pitas R.E., Wilson B.D., and Rodgers G.M. Oxidized low-density lipoprotein increases cultured human endothelial cell tissue factor activity and reduces protein C activation. FASEB J. 5 (1991) 2459-2465
121. Welch G., and Loscalzo J. Nitric oxide and the cardiovascular system. J. Cardiovasc. Surg. 9 (1994) 361-371
122. Yoshida Y., Tsuchiya J., and Niki E. Interaction of α-tocopherol with copper and its effect on lipid peroxidation. Biochim. Biophys. Acta 1200 (1994) 85-92